Cargando…

Multiple immune function impairments in diabetic patients and their effects on COVID-19

Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2, poses a significant threat to public health worldwide, and diabetes is considered a risk factor for the rapid progression and poor prognosis of COVID-19. Limited immune function is a clinical fea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Zhong-Hua, Yu, Wei-Li, Sun, Yun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409204/ https://www.ncbi.nlm.nih.gov/pubmed/34540952 http://dx.doi.org/10.12998/wjcc.v9.i24.6969

Ejemplares similares

An Impaired Inflammatory and Innate Immune Response in COVID-19
por: Park, Sung Ho
Publicado: (2021)

Multiple influences of the COVID-19 pandemic on children with diabetes: Changes in epidemiology, metabolic control and medical care
por: Zucchini, Stefano, et al.
Publicado: (2023)

COVID-19 and hyperglycemia/diabetes
por: Michalakis, Konstantinos, et al.
Publicado: (2021)

Gastrointestinal mucosal immunity and COVID-19
por: Velikova, Tsvetelina, et al.
Publicado: (2021)

Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy
por: Vasilev, Georgi, et al.
Publicado: (2022)

COVID-19 vaccination and diabetic ketoacidosis
por: Joob, Beuy, et al.
Publicado: (2023)

Children with type 1 diabetes in COVID-19 pandemic: Difficulties and solutions
por: Shi, Yue, et al.
Publicado: (2022)

Management of hip fracture in COVID-19 infected patients
por: Qin, Hao-Cheng, et al.
Publicado: (2022)

Effect of COVID-19 on management of type 1 diabetes: Pushing the boundaries of telemedical healthcare
por: Bilic Curcic, Ines, et al.
Publicado: (2021)

COVID-19 and liver dysfunction: What nutritionists need to know
por: Wang, Ming-Ke, et al.
Publicado: (2022)

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
por: Gangadharan, Charitha, et al.
Publicado: (2021)

Immune-mediated liver injury following COVID-19 vaccination
por: Schinas, Georgios, et al.
Publicado: (2023)

COVID-19 associated diabetes mellitus: A review
por: Gavkare, Ajay M, et al.
Publicado: (2022)

Liver function in COVID-19 infection
por: Przekop, Dagmara, et al.
Publicado: (2021)

Effect of resveratrol in gestational diabetes mellitus and its complications
por: Ma, Hui-Zhong, et al.
Publicado: (2023)

Diabetes mellitus and COVID-19: Understanding the association in light of current evidence
por: Sen, Saikat, et al.
Publicado: (2021)

Treatment strategies for gastric cancer during the COVID-19 pandemic
por: Kang, Wen-Zhe, et al.
Publicado: (2020)

MiT Family Transcriptional Factors in Immune Cell Functions
por: Kim, Seongryong, et al.
Publicado: (2021)

Chest radiological finding of COVID-19 in patients with and without diabetes mellitus: Differences in imaging finding
por: Gangadharan, Sunay, et al.
Publicado: (2022)

Standardization of critical care management of non-critically ill patients with COVID-19
por: Wang, Chang-Song, et al.
Publicado: (2021)

Humoral Immunity against SARS-CoV-2 and the Impact on COVID-19 Pathogenesis
por: Lee, Eunjin, et al.
Publicado: (2021)

Multiple roles for cholinergic signaling in pancreatic diseases
por: Yang, Jun-Min, et al.
Publicado: (2022)

Telemedicine in the COVID-19 era: Taking care of children with obesity and diabetes mellitus
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2021)

Advances in neovascularization after diabetic ischemia
por: Cai, Yue, et al.
Publicado: (2022)

Effects of COVID-19 on children with autism
por: Al-Beltagi, Mohammed, et al.
Publicado: (2022)

Liver function in transgender persons: Challenges in the COVID-19 era
por: Milionis, Charalampos, et al.
Publicado: (2023)

Alphabet strategy for diabetes care: A checklist approach in the time of COVID-19 and beyond
por: Upreti, Rajeev, et al.
Publicado: (2021)

Therapeutic prospects of mesenchymal stem/stromal cells in COVID-19 associated pulmonary diseases: From bench to bedside
por: Zhang, Lei-Sheng, et al.
Publicado: (2021)

Real role of growth factor receptor-binding protein 10: Linking lipid metabolism to diabetes cardiovascular complications
por: Yang, Yang, et al.
Publicado: (2022)

Immune function keeps endosymbionts under control
por: Reynolds, Stuart, et al.
Publicado: (2008)

Effect of oncometabolic surgery on gastric cancer: The remission of hypertension, type 2 diabetes mellitus, and beyond
por: Cheng, Yu-Xi, et al.
Publicado: (2021)

Advanced-glycation end-products axis: A contributor to the risk of severe illness from COVID-19 in diabetes patients
por: Rojas, Armando, et al.
Publicado: (2021)

Effects of anti-diabetic drugs on sarcopenia: Best treatment options for elderly patients with type 2 diabetes mellitus and sarcopenia
por: Ma, Xiao-Yu, et al.
Publicado: (2021)

Inflammatory effect on the gastrointestinal system associated with COVID-19
por: Delgado-Gonzalez, Paulina, et al.
Publicado: (2021)

Effectiveness and safety of COVID-19 vaccines in patients with oncological diseases: State-of-the-art
por: Ivanov, Nedelcho, et al.
Publicado: (2023)

Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
por: Sun, Jin, et al.
Publicado: (2023)

Role and function of granin proteins in diabetes mellitus
por: Herold, Zoltan, et al.
Publicado: (2021)

Impact of COVID-19 on liver
por: Su, Yu-Jang, et al.
Publicado: (2021)

COVID-19 and gastroenteric manifestations
por: Chen, Zhang-Ren, et al.
Publicado: (2021)

Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosis
por: Liu, Xiao-Na, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8n8u95pr9uj1a3j2hsdtp60uqo